During the past decade, Fondazione Salvatore Maugeri conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 14 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fondazione Salvatore Maugeri" #1 sponsor was "Istituti Clinici Scientifici Maugeri SpA" with 7 trials, followed by "ETOP IBCSG Partners Foundation" with 5 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 5 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 4 trials sponsored and "National Cancer Institute, Naples" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fondazione Salvatore Maugeri" #1 collaborator was "Breast International Group" with 5 trials as a collaborator, "Clinical Research Technology S.r.l." with 3 trials as a collaborator, "Associazione Italiana per la Ricerca sul Cancro" with 2 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Fondazione Salvatore Maugeri" are "Breast Cancer" (12 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Chronic Respiratory Failure" (2 trials), "Colorectal Cancer" (2 trials) and "Non-small Cell Lung Cancer Metastatic" (2 trials). Many other conditions were trialed in "Fondazione Salvatore Maugeri" in a lesser frequency.

Most popular intervention types in "Fondazione Salvatore Maugeri" are "Drug" (47 trials), "Device" (9 trials), "Other" (7 trials), "Procedure" (7 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cyclophosphamide" (4 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Salvatore Maugeri" are 52 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Fondazione Salvatore Maugeri". undefined are not yet recruiting, 11 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Fondazione Salvatore Maugeri, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Salvatore Maugeri, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".